Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments

被引:22
作者
Kucuk, E. V. [1 ]
Tahra, A. [2 ]
Bindayi, A. [2 ]
Onol, F. F. [2 ]
机构
[1] Hlth Sci Univ, Umraniye Training & Res Hosp, Urol, Istanbul, Turkey
[2] Hlth Sci Univ, Umraniye Training & Res Hosp, Istanbul, Turkey
关键词
erectile dysfunction; tadalafil; intracavernosal injection; penile prosthesis; QUALITY-OF-LIFE; TREATMENT SATISFACTION; SILDENAFIL CITRATE; ON-DEMAND; EFFICACY; OUTCOMES; THERAPY; SAFETY; SELF; MEN;
D O I
10.1111/andr.12237
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
There are various treatment modalities for erectile dysfunction with different success and satisfaction rates. We aim to compare patient satisfaction with tadalafil, intracavernosal injection, and penile prosthesis implantation in patients with erectile dysfunction. The records of 3448 men with erectile dysfunction were evaluated retrospectively. A total of 356 men with organic erectile dysfunction were enrolled into this study. Of these patients, 132 (37%) received tadalafil 20 mg twice a week for 12 weeks, 106 (30%) patients received tadalafil 5 mg once-daily for 12 weeks, 96 (27%) patients used intracavernosal injection therapy (Bi-mix; papaverine and phentolamine). Moreover, 22 patients underwent penile prosthesis implantation. Patient and partner satisfaction were assessed with International Index of Erectile Function (IIEF) and Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire. Patients' mean age was 52.4 +/- 25.76 (32-71). The etiology of erectile dysfunction was chronic systemic diseases in 133 (44%) and radical prostatectomy in 121 patients (40%). The mean IIEF-5 scores improvement after the treatment was higher in penile prosthesis implantation group (12.4 +/- 1.3) compared with tadalafil 5 mg (6.7 +/- 1.5) (p < 0.01), tadalafil 20 mg (6.2 +/- 1.5) (p < 0.01), and intracavernosal injection group (8.4 +/- 3.2) (p < 0.05). The EDITS score was significantly higher in penile prosthesis implantation group (78.2 +/- 11.3) compared with intracavernosal injection (60.3 +/- 6.3), tadalafil 5 mg (72.5 +/- 4.5), and tadalafil 20 mg 70.7 +/- 3.4 groups (p < 0.05). Partners' EDITS scores were 70.1 +/- 10 in penile prosthesis implantation group, 50.2 +/- 1.5 in intracavernosal injection group, 62.9 +/- 7.8 in tadalafil 5 mg, and 61.3 +/- 5.3 in tadalafil 20 mg group (p < 0.05). Erectile dysfunction patients who underwent penile prosthesis implantation seem to be more satisfied compared with tadalafil treatment and intracavernosal injection. Future clinical trials are warranted to confirm our results.
引用
收藏
页码:952 / 956
页数:5
相关论文
共 50 条
[41]   Satisfaction and surgical outcomes in patients undergoing penile prosthesis implantation for drug-refractory erectile dysfunction: mid-term results in a single center French cohort [J].
Dardenne, Emilie ;
Manach, Quentin ;
Grande, Pietro ;
Campi, Riccardo ;
Gomez, Florie ;
Granger, Benjamin ;
Misrai, Vincent ;
Bitker, Marc-Olivier ;
Mozer, Pierre ;
Roupret, Morgan .
CANADIAN JOURNAL OF UROLOGY, 2019, 26 (06) :10039-10044
[42]   Intracavernosal self-injection therapy in men with erectile dysfunction: Satisfaction and attrition in 119 patients [J].
Rowland, DL ;
Boedhoe, HSM ;
Dohle, G ;
Slob, AK .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 1999, 11 (03) :145-151
[43]   Intracavernosal self-injection therapy in men with erectile dysfunction: Satisfaction and attrition in 119 patients [J].
DL Rowland ;
HSM Boedhoe ;
G Dohle ;
AK Slob .
International Journal of Impotence Research, 1999, 11 :145-151
[44]   Intraoperative methods for residual curvature correction during penile prosthesis implantation in patients with Peyronie's disease and refractory erectile dysfunction [J].
El-Khatib, Farouk M. ;
Huynh, Linda M. ;
Yafi, Faysal A. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2020, 32 (01) :43-51
[45]   Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin El intracavernosal injection therapy to oral sildenafil citrate [J].
Montorsi, F ;
Althof, SE ;
Sweeney, M ;
Menchini-Fabris, F ;
Sasso, F ;
Giuliano, F .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2003, 15 (06) :444-449
[46]   Combined Implantation of a Penile Prosthesis and Adjustable Continence Therapy ProACT in Patients with Erectile Dysfunction and Urinary Incontinence after Radical Prostatectomy: Results of a Prospective Pilot Study [J].
Yiou, Rene ;
Binhas, Michele .
JOURNAL OF SEXUAL MEDICINE, 2015, 12 (12) :2481-2484
[47]   Long-term results of three-part penile prosthesis implantation with Ectopic reservoir placement in the treatment of erectile dysfunction: is supramuscular tubulation a reliable method? [J].
Bozkurt, Yunus Erol ;
Akdeniz, Caner Bugra ;
Gumus, Bilali Habes .
BASIC AND CLINICAL ANDROLOGY, 2024, 34 (01)
[48]   A comprehensive narrative review of residual curvature correction during penile prosthesis implantation in patients with severe erectile dysfunction and concomitant Peyronie's disease [J].
Sokolakis, Ioannis ;
Pyrgidis, Nikolaos ;
Mykoniatis, Ioannis ;
Dimitriadis, Fotios ;
Hatzichristodoulou, Georgios .
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (06) :2669-2681
[49]   Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E1 intracavernosal injection therapy to oral sildenafil citrate [J].
F Montorsi ;
SE Althof ;
M Sweeney ;
F Menchini-Fabris ;
F Sasso ;
F Giuliano .
International Journal of Impotence Research, 2003, 15 :444-449
[50]   Penile prosthesis for erectile dysfunction in the neurological patient, indication, complications and satisfaction: Retrospective study on 27 patients [J].
Xardel, V ;
Guy, L. ;
Neuville, P. ;
Journel, N. Morel .
PROGRES EN UROLOGIE, 2021, 31 (04) :223-230